Revvity Raises 2025 Profit and Revenue Forecasts Amid Strong Demand
Revvity has increased its 2025 profit and revenue forecasts due to strong demand for its services. The company expects adjusted profit per share to exceed $4.90-$5.00 and annual revenue to reach $2.86 billion, surpassing Wall Street expectations.
Insights:
Revvity Inc , a leading medical equipment and contract research services provider, announced an upward revision of its 2025 financial guidance, signaling robust demand for its offerings. The company now anticipates its adjusted profit per share to surpass the previous forecast range of $4.90 to $5.00. Additionally, Revvity has raised its full-year revenue guidance to $2.86 billion, reflecting a 4% growth, exceeding Wall Street's estimate of $2.84 billion.
